PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $798,000 | -36.7% | 138,461 | 0.0% | 1.44% | -22.6% |
| Q2 2019 | $1,260,000 | -34.4% | 138,461 | 0.0% | 1.86% | -28.4% |
| Q1 2019 | $1,920,000 | -12.1% | 138,461 | 0.0% | 2.60% | -45.9% |
| Q4 2018 | $2,185,000 | -18.4% | 138,461 | 0.0% | 4.81% | -24.8% |
| Q3 2018 | $2,679,000 | +138.6% | 138,461 | -10.0% | 6.40% | +162.7% |
| Q2 2018 | $1,123,000 | +137.4% | 153,846 | 0.0% | 2.44% | +162.4% |
| Q1 2018 | $473,000 | -52.3% | 153,846 | -50.0% | 0.93% | +8.2% |
| Q4 2017 | $992,000 | – | 307,692 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |